prof. RNDr. Blanka Říhová, DrSc.

Vedoucí vědecká pracovnice

Publikace

Journal of Controlled Release. 2025; 381(May 10); 113645

Overcoming P-glycoprotein-mediated multidrug resistance in cancer cells through micelle-forming PHPMA-b-PPO diblock copolymers for doxorubicin delivery

Journal for ImmunoTherapy of Cancer. 2025; 13(8); e010465

Temporal optimization of CD25-biased IL-2 agonists and immune checkpoint blockade leads to synergistic anticancer activity despite robust regulatory T cell expansion

In: Biografický slovník českých zemí. Sešit 25. Hl-Hol. Praha: Academia; 2022; s. 796-797

Holub; Miroslav

Biomacromolecules. 2022; 23(6); 2522-2535

Simultaneous delivery of doxorubicin and protease inhibitor derivative to solid tumors via star-shaped polymer nanomedicines overcomes P-gp- and STAT3-mediated chemoresistance

Journal of Controlled Release. 2021; 332(APR 10 2021); 563-580

Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling

Pharmaceutics. 2021; 13(2); 179

HPMA-based copolymers carrying STAT3 inhibitor cucurbitacin-D as stimulus-sensitive nanomedicines for oncotherapy

Journal of Controlled Release. 2020; 321(10 May); 718-733

Polymer nanomedicines based on micelle-forming amphiphilic or water-soluble polymer-doxorubicin conjugates: comparative study of in vitro and in vivo properties related to the polymer carrier structure; composition; and hydrodynamic properties